MYOG and soft tissue sarcoma: RMS accounts for 50% of all pediatric soft-tissue sarcoma cases and the tumors express proteins such as myogenin (MyoG), desmin and MyoD that are indicative of immature skeletal muscle [reviewed in (1–3)].